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Iodine deficiency is not only a problem in developing regions; it also affects many indus-
trialised countries. Globally, two billion individuals have an insufficient iodine intake, and
approximately 50% of continental Europe remains mildly iodine deficient. Iodine intakes in
other industrialised countries, including the USA and Australia, have fallen in recent years.
Iodine deficiency has reappeared in Australia, as a result of declining iodine residues in milk
products because of decreased iodophor use by the dairy industry. In the USA, although the
general population is iodine sufficient, it is uncertain whether iodine intakes are adequate in
pregnancy, which has led to calls for iodine supplementation. The few available data suggest
that pregnant women in the Republic of Ireland and the UK are now mildly iodine deficient,
possibly as a result of reduced use of iodophors by the dairy industry, as observed in Australia.
Representative data on iodine status in children and pregnant women in the UK are urgently
needed to inform health policy. In most industrialised countries the best strategy to control
iodine deficiency is carefully-monitored salt iodisation. However, because approximately
90% of salt consumption in industrialised countries is from purchased processed foods, the
iodisation of household salt only will not supply adequate iodine. Thus, in order to successfully
control iodine deficiency in industrialised countries it is critical that the food industry use
iodised salt. The current push to reduce salt consumption to prevent chronic diseases and the
policy of salt iodisation to eliminate iodine deficiency do not conflict; iodisation methods can
fortify salt to provide recommended iodine intakes even if per capita salt intakes are reduced to
<5 g/d.
Iodine deficiency: Goitre: Industrialised countries: Thyroid disorders
Many industrialised countries are areas of historical
iodine deficiency and goitre
Iodine (as iodide) is widely but unevenly distributed in
the earth’s environment. In many regions leaching from
glaciation, flooding and erosion have depleted surface soils
of iodide and most iodide is found in the oceans. Iodide
ions in seawater are oxidised to elemental iodine, which
volatilises into the atmosphere and is returned to the soil
by rain, completing the cycle(1). However, iodine cycling
in many regions is slow and incomplete, leaving soils and
drinking water depleted of iodine. Crops grown in these
soils will be low in iodine and human populations and
animals consuming food grown in these soils become
iodine deficient. Iodine-deficient soils are common in
industrialised countries; well-known examples are the
Alpine region of Europe, the Midwest in North America,
southern Australia and inland areas of western England and
Wales. Iodine deficiency and goitre in these areas persists
until iodine enters the food chain through the addition
of iodine to foods (e.g. iodisation of salt) or dietary diver-
sification introduces foods produced outside the iodine-
deficient area.
Iodine is an essential component of the hormones
thyroxine and triiodothyronine produced by the thyroid
gland(2). Thyroid hormones, and therefore iodine, are
Abbreviations: NHANES, National Health and Nutrition Examination Survey; TSH, thyroid-stimulating hormone; UI, urinary iodine concentration.
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essential for mammalian life. In 1917 it was shown that
thyroid enlargement (goitre) is caused by iodine deficiency
and can be prevented by iodine supplementation(3). Goitre
prophylaxis through salt iodisation was first introduced in
industrialised countries (Switzerland and the USA) in the
early 1920s(4). In 1980 the first global estimate from WHO
on the prevalence of goitre was reported; it was estimated
that 20–60% of the world’s population were iodine de-
ficient and/or goitrous, with most of the burden in develop-
ing countries. During the period of 1970–1990 it was
shown in controlled studies in iodine-deficient regions that
iodine supplementation not only eliminates new cases of
cretinism but also reduces infant mortality and improves
cognitive function in the rest of the population(5). Pro-
grammes to correct iodine deficiency were considered to
have clear political appeal because its human, economic
and social consequences could be averted by a low-cost
intervention, universal salt iodisation. Since 1990 elimin-
ation of iodine deficiency has been an integral part of
national nutrition strategies in most developing countries.
In contrast, it has received little attention from public
health authorities in many industrialised countries.
Dietary sources, absorption and requirements
The native iodine content of most foods and beverages
is low. In general, commonly-consumed foods provide
3–80mg per serving(6,7). Foods of marine origin have
higher iodine contents because marine plants and animals
concentrate iodine from seawater. In the USA the median
intake of iodine from food in the mid-1990s was estimated
to be 240–300mg/d for men and 190–210mg/d for
women(8). Major dietary sources of iodine in the USA are
bread and milk(9). In Switzerland, based on direct food
analysis, mean intake of dietary iodine is approximately
140mg/d, mainly from bread and dairy products(7). In many
countries the use of iodised salt in households for cooking
and at the table provides additional iodine. The iodine
content of foods is also influenced by iodine-containing
compounds used in irrigation, fertilisers and livestock
feed. Iodophors used for cleaning milk cans and teats can
increase the native iodine content of dairy products. Tra-
ditionally, iodate was used in bread making as a dough
conditioner, but it is being replaced by non-iodine-con-
taining conditioners, such as bromate. Dietary supplements
often contain iodine. Based on data from National Health
and Nutrition Examination Survey (NHANES) III (1988–
1994) it has been estimated that supplements containing
iodine are taken by 12% of men and 15% of non-pregnant
women, the median intake of iodine from supplements
being approximately 140mg/d for adults(8). Other sources
of iodine include water purification tablets, radiographic
contrast media, medicines (e.g. amiodarone) and skin dis-
infectants (e.g. povidone-iodine contains approximately
10 mg/ml).
Iodine is ingested in several chemical forms. Iodide is
rapidly and nearly completely absorbed in the stomach
and duodenum. Iodate, widely used in salt iodisation, is
reduced in the gut and absorbed as iodide. In healthy adults
the absorption of iodide is >90%(10). Organically-bound
iodine is typically digested and the released iodide ab-
sorbed. The body of a healthy adult contains 15–20 mg
iodine, of which 70–80% is in the thyroid. In chronic
iodine deficiency the iodine content of the thyroid may fall
to <20mg(11). In iodine-sufficient areas the adult thyroid
traps approximately 60mg iodine/d to balance losses and
maintain thyroid hormone synthesis(11). Iodine comprises
65 and 59% of thyroxine and triiodothyronine by weight
respectively. Degradation of thyroxine and triiodothy-
ronine in the periphery releases iodine that enters the
plasma iodine pool and can be taken up by the thyroid or
excreted by the kidney(11). Of the ingested iodine >90% is
ultimately excreted in the urine. WHO recommendations
for iodine intake are shown in Table 1; the WHO recom-
mended nutrient intake for iodine is the intake estimated to
cover the needs of ‘nearly all’ healthy individuals at the
specified life stage(12).
Methods to assess iodine status
Four methods are generally recommended for assessment
of iodine nutrition in populations(12): the goitre rate; uri-
nary iodine concentration (UI); blood thyroid-stimulating
hormone (TSH); blood thyroglobulin. These indicators are
complementary, in that UI is a sensitive indicator of recent
iodine intake (days) and thyroglobulin shows an inter-
mediate response (weeks to months), whereas changes in
the goitre rate reflect long-term iodine nutrition (months to
years). These methods have recently been extensively
reviewed(13). WHO recommends the use of total goitre rate
to define severity of iodine deficiency in populations (sur-
veys are usually conducted in school-age children) with the
following criteria: <5%, iodine sufficiency; 5.0–19.9%,
mild deficiency; 20.0–29.9%, moderate deficiency; >30%,
severe deficiency(12). The median UI from a representative
sample of spot urine collections from different population
groups is the most common way to classify a population’s
iodine status (Table 2). The median UI is recommended for
assessing iodine nutrition in pregnant women, and recently
WHO have recommended 150–249mg/l as the median UI
that indicates adequate iodine intake during pregnancy(12)
(Table 2). A collection method and a new reference range
for UI in newborns in the first week after birth has recently
become available(14). Although UI does not provide direct
information on thyroid function, a low value suggests that
a population is at higher risk of developing thyroid dis-
orders.
TSH is used in many industrialised countries for routine
newborn screening to detect congenital hypothyroidism;
Table 1. WHO recommendations for iodine intake (mg/d)(12) by age
or population group
Age or population group RNI
Children 0–5 years 90
Children 6–12 years 120
Adults >12 years 150
Pregnancy 250
Lactation 250
RNI, recommended nutrient intake.
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such screening offers a sensitive indicator of iodine
nutrition in the newborn period(12). Newborn TSH is an
important measure because it reflects iodine status during a
period when the developing brain is particularly sensitive
to iodine deficiency. Serum TSH concentrations are tran-
siently increased in iodine-deficient infants for the first few
weeks of life, a condition termed transient newborn hypo-
thyroidism. In areas of iodine deficiency an increase in
transient newborn hypothyroidism, indicated by >3% of
newborn TSH values above the threshold of 5 mU/l whole
blood collected 3–4 d after birth, suggests iodine deficiency
in the population(12). Recent data from a large representa-
tive Swiss study suggest that newborn TSH is a sensitive
indicator of even marginal iodine nutrition in pregnancy(15).
A new assay for thyroglobulin has been developed for dried
blood spots taken by a finger prick(16), simplifying collec-
tion and transport. Dried blood spot thyroglobulin has been
shown to be a sensitive measure of iodine status(16,17) and
recently a reference standard and an international reference
range in iodine-sufficient schoolchildren (4–40mg/l) has
been made available(16). In contrast, thyroid hormone con-
centrations are generally poor indicators of iodine status(12),
unless iodine deficiency is severe.
Epidemiology of iodine deficiency in industrialised
countries
Only a few countries (Switzerland, some of the Scandina-
vian countries, Australia, the USA and Canada) were
recognised as being clearly iodine sufficient before 1990.
Since then, globally, the number of households using
iodised salt has risen from <20% to >70%, dramatically
reducing iodine deficiency(18). Currently, WHO estimates
that approximately two billion individuals have an insuffi-
cient iodine intake, including one-third of all school-age
children(19) (Table 3). The WHO prevalence data empha-
sise that iodine deficiency is not only a problem of de-
veloping countries; the highest prevalence of iodine
deficiency is in Europe (52.0%), where the household
coverage with iodised salt is the lowest (approximately
25%), and many of these countries have weak or non-
existent control programmes for iodine-deficiency dis-
orders(20). There are several limitations to these WHO
prevalence data. First, extrapolation from a population
Table 2. WHO epidemiological criteria for the assessment of iodine nutrition in a population based on medians or ranges of urinary iodine
concentrations (mg/l)(12)*
Iodine intake Iodine nutrition
School-aged children
<20 Insufficient Severe iodine deficiency
20–49 Insufficient Moderate iodine deficiency
50–99 Insufficient Mild iodine deficiency
100–199 Adequate Optimum
200–299 More than adequate Risk of iodine-induced hyperthyroidism in susceptible groups
>300 Excessive Risk of adverse health consequences (iodine-induced
hyperthyroidism, autoimmune thyroid disease)
Pregnant women
<150 Insufficient
150–249 Adequate
250–499 More than adequate
‡ 500 Excessive‡
Lactating women†
<100 Insufficient
‡ 100 Adequate
Children <2 years of age
<100 Insufficient
‡ 100 Adequate
*There is no information about iodine nutrition for pregnant and lactating women in the WHO assessment table, and the upper limits of the median urinary iodine for
lactating women and children <2 years of age are not specified.
†The values for median urinary iodine are lower than the iodine requirements, because of the iodine excreted in breast milk.
‡In excess of the amount needed to prevent and control iodine deficiency.
Table 3. Prevalence of iodine deficiency (total number (millions)
and percentage) in the general population (all age-groups) and in
school-age children (6–12 years) in 2007(19)
WHO regions*
Population with urinary iodine <100mg/l†
General population School-age children
n % n %
Africa 312.9 41.5 57.7 40.8
Americas 98.6 11.0 11.6 10.6
Eastern Mediterranean 259.3 47.2 43.3 48.8
Europe 459.7 52.0 38.7 52.4
Southeast Asia 503.6 30.0 73.1 30.3
Western Pacific 374.7 21.2 41.6 22.7
Total 2000.0 30.6 263.7 31.5
*193 WHO member states.
†Based on population estimates for 2006(83).
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indicator (median UI) to define the number of individuals
affected is problematic, e.g. a country in which children
have a median UI of 100mg/l would be classified as being
iodine sufficient, yet at the same time 50% of children
would be classified as having inadequate iodine intakes.
Second, nationally-representative surveys represent only
60% of the global population included in the WHO data,
and sub-national data may under- or overestimate the
extent of iodine deficiency(19). Finally, there are insuffi-
cient data from the majority of the countries to estimate the
prevalence of iodine deficiency in pregnant women.
Effects of mild-to-moderate iodine deficiency
Pregnancy
Iodine deficiency, when severe, has multiple adverse
effects on growth and development in animals and human
subjects, collectively termed the iodine-deficiency dis-
orders(3,4). The adverse effects on pregnancy of mild iodine
deficiency, typical of industrialised countries, remain
unclear. Six controlled trials of iodine treatment in preg-
nant women with iodine deficiency have been conducted in
Europe(21–26). Overall, these studies suggest that in areas of
mild-to-moderate iodine deficiency the maternal thyroid
is able to adapt to meet the increased thyroid hormone
requirements of pregnancy(27). Although supplementation
in these studies was generally found to be effective in
minimising an increase in thyroid size during pregnancy,
only two of the six studies report that maternal TSH is
lower (within the normal reference range) with supple-
mentation, and none of the studies show a marked impact
of supplementation on maternal and newborn total or
free thyroid hormone concentrations(27). Thyroid hormone
concentrations may be the best surrogate biochemical
marker for healthy fetal development. Thus, the results of
these trials are reassuring. However, because none of
the trials measured long-term clinical outcomes such as
maternal goitre or infant development, the potential
adverse effects of mild-to-moderate iodine deficiency
during pregnancy remain uncertain. In industrialised
countries with iodine deficiency it has often been suggested
that pregnancy is an environmental factor contributing to a
higher prevalence of goitre and thyroid disorders in
women, compared with men. However, the data to support
this premise are scarce. In European studies data from an
uncontrolled prospective study in ten women(28), a retro-
spective study(29) and a cross-sectional study in smoking
women(30) suggest goitres formed during pregnancy may
only partially regress after parturition.
Childhood
There have been many cross-sectional studies comparing
cognition and/or motor function in children from chroni-
cally iodine-deficient and iodine-sufficient areas, including
children from European backgrounds(31–35). These cross-
sectional studies generally report reduced intellectual
function and motor skills in children from iodine-deficient
areas. However, observational studies are often con-
founded by other factors that affect child development.
Furthermore, these studies could not distinguish between
the persistent effects of in utero iodine deficiency and the
effects of current iodine status. Two meta-analyses have
reported on this issue(36,37), but they have included mainly
data from regions of chronic severe iodine deficiency; in
such areas populations experience a mean reduction in
intelligence quotient of 12–13.5 points.
In a recent placebo-controlled double-blind 6-month
intervention trial 10–12-year-old children with moderate
iodine deficiency (n 310) in Albania were randomised to
receive either 400 mg iodine as oral iodised oil or placebo.
It was found that compared with placebo iodine treatment
improves performance on tests of information processing,
fine motor skills and visual problem solving(38). These
findings have recently been confirmed in mildly-iodine-
deficient New Zealand children(39). Thus it appears that in
children born and raised in areas of moderate iodine defi-
ciency cognitive impairment is at least partially reversible
by iodine repletion(38,39). In addition, recent controlled
studies clearly demonstrate that iodine repletion in school-
age children with iodine deficiency increases insulin-like
growth factor-1 and insulin-like growth factor-binding
protein-3 concentrations; in children who have moderate-
to-severe deficiency their somatic growth is improved(40).
Chronic iodine deficiency increases the TSH concentration
and produces a thyroid hormone pattern consistent with
subclinical hypothyroidism(11), and subclinical hypothyroid-
ism may increase the risk of CVD. Iodised oil rapidly
normalises the increased TSH concentrations found in
individuals who are iodine-deficient(11) and thus corrects
subclinical hypothyroidism. An uncontrolled study has
reported that iodine treatment of German adolescents
who are goitrous decreases plasma cholesterol concen-
trations(41). A recent controlled study has reported that in
children with moderate iodine deficiency and elevated
TSH concentrations as a result of iodine deficiency iodine
treatment of improves their lipid profile and reduces their
insulin (C-peptide) levels compared with controls(42). This
previously unrecognised benefit of iodine prophylaxis may
be important because iodine deficiency remains common
in many industrialised countries with increasing rates of
obesity and CVD.
Treatment and prevention
Salt fortification with iodine
In the majority of industrialised countries affected by
iodine deficiency the most effective way to control iodine
deficiency is through salt iodisation(12). Salt iodisation is
the recommended strategy for control of iodine deficiency
because: (1) salt is one of few foodstuffs consumed by
virtually every individual; (2) salt intake is fairly consistent
through the year; in many countries salt production and
importation is limited to a few sources; (3) iodisation
technology is simple and relatively inexpensive to imple-
ment; (4) the addition of iodine to salt does not affect its
colour or taste; (5) the quantity of iodine in salt can be
simply monitored at the production, retail and household
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levels. WHO/UNICEF/International Council for the Control
of Iodine Deficiency Disorders recommends that iodine is
added at a level of 20–40 mg iodine/kg salt, depending
on local salt intake(12). Salt iodisation remains the most
cost-effective way of delivering iodine and of improving
cognition in populations who are iodine deficient(43).
Worldwide, the annual costs of salt iodisation are esti-
mated to be US$ 0.02–0.05 per child covered, and the costs
per child death averted are US$ 1000 and per disability-
adjusted life-year gained are US$ 34–36(44).
The importance of food industry use of iodised salt
in industrialised countries
WHO recommends universal salt iodisation to control
iodine deficiency(12). Universal salt iodisation is a term
used to describe the iodisation of all salt for human (food
industry and household) and livestock consumption.
Although the ideal, even in countries with successful salt
iodisation programmes, universal salt iodisation is rarely
achieved, as many countries do not iodise all salt for live-
stock and food industries are often reluctant to use iodised
salt. The limited use of iodised salt by the food industry is
one of the main reasons for iodine deficiency in many
industrialised countries. In countries such as England and
Denmark household salt, i.e. salt for cooking and table use,
contributes only 8–15% to total salt intakes; most of the
remainder comes from purchased processed foods(45,46).
Thus, in industrialised countries, where on average total
adult per capita salt consumption is approximately 10 g/d,
only about 1 g household salt is consumed daily(46). If the
food industry uses non-iodised salt and only household salt
is iodised (at WHO recommended levels of 20 mg iodine/
kg salt), then total iodine intake from iodised salt will only
be approximately 20mg/d, far below the daily requirement
for all age-groups. Thus, in order to successfully control
iodine deficiency in industrialised countries it is critical
to convince the food industry to begin to use iodised
salt in their products. For example, in The Netherlands
all salt used by the baking industry is iodised, and this
source is the major contributor to iodine sufficiency in
the country(20). Switzerland’s long-running iodised salt
programme has been successful partly because approxi-
mately 60% of salt used by the food industry is iodised
on a voluntary basis. As iodine at mg/g levels in iodised
salt does not cause colour or flavour changes in any foods
and in most countries the price difference between iodised
and non-iodised salt is negligible, there should be no
major barriers to adoption of iodised salt by food manu-
facturers.
How to reconcile the policy of reducing salt consumption
to prevent chronic diseases and the policy of universal
salt iodisation to eliminate iodine deficiency
Current WHO recommendations to prevent chronic diseases
state that the population average per capita consumption of
salt should be <5 g/d (<2 g Na/d)(47). However, the WHO
recommendation that salt be fortified with iodine at a level
of 20–40mg/g is based on the assumption of an average
salt intake of approximately 10 g/d at the population
level(12). Thus, the level of iodine fortification may need
to be adjusted by national salt iodisation programmes if
health authorities are successful in reducing salt con-
sumption. Since iodisation methods can easily fortify salt
with adequate concentrations of iodine to provide recom-
mended iodine intakes even if per capita salt intake falls
to <5 g/d, these two important health policies are not in
conflict(47). Interaction with food manufacturers in indus-
trialised countries will be fundamental to the success of
both salt-reduction strategies and to universal salt iodi-
sation.
Other fortification vehicles
Bread can be an effective vehicle for iodine by including
baker’s salt enriched with iodine(48). Although iodising
drinking water or irrigation water can also be effective(49),
the higher cost and the complexity of monitoring are dis-
advantages. In Finland iodine-fortified animal fodder has
increased the iodine content of foods derived from animal
sources. In countries with iodine deficiency iodine should
be routinely added to complementary foods or add-on for-
mulas for infants during weaning to provide approximately
90mg iodine/d(50).
Iodine supplementation
In some regions iodisation of salt may not be practical for
control of iodine deficiency, at least in the short term, and
iodine supplements can be used (Table 4)(12). Iodised oil
supplements are prepared by esterification of the unsatu-
rated fatty acids in seed or vegetable oils and addition of
iodine to the double bonds. It can be given orally or by
intramuscular injection(12). The intramuscular route has a
longer duration of action, but oral administration is more
common because it is simpler. Usual doses are 200–
400 mg iodine/year(12) and it is often targeted to women of
child-bearing age, pregnant women and children. Its dis-
advantages are an uneven level of iodine in the body over
time and the need for direct contact with individuals with
the accompanying increased costs. Iodine can also be given
as potassium iodide or potassium iodate as drops or tablets.
Single oral doses of potassium iodide monthly (30 mg) or
biweekly (8 mg) can provide adequate iodine for school-
age children(51).
Strategies to prevent or correct deficiency during
pregnancy and lactation
For nearly all industrialised countries the primary strategy
for sustainable elimination of iodine deficiency in preg-
nancy remains salt iodisation(12). In countries or regions in
which a salt iodisation programme covers ‡90% of house-
holds and has been sustained for ‡2 years, and the median
UI indicates iodine sufficiency (Table 4), pregnant and
lactating women do not need iodine supplementation(12).
Several countries with long-standing successful iodised salt
programmes have reported an optimal median UI in preg-
nant women(27). Moreover, in countries affected by mild or
moderate iodine deficiency (Republic of Ireland, Germany,
Belgium, Italy, Denmark) thyroid volume increases
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15–31% during pregnancy, while in iodine-sufficient
countries (Finland, The Netherlands) there is little or no
increase in thyroid volume during pregnancy(52). These
data suggest that effective salt iodisation can provide
adequate iodine intake during pregnancy, but iodine-
containing supplements taken during the prenatal
period may have contributed to iodine intakes in these
studies.
Implementation of salt iodisation is not always feasible,
and non-implementation may result in inadequate iodine
supply for women of child-bearing age and pregnant
women. In this situation supplementation of these groups
should be considered. WHO recommends that countries
assess their salt iodisation programmes and then decide
whether supplementation is indicated(12). In order to ensure
adequate iodine supply during pregnancy women should
ideally be provided with adequate iodine intake (‡ 150
mg/d) for a long period before conception to ensure plen-
tiful intrathyroidal iodine stores(53). In Italy thyroid func-
tion in pregnant women from a mildly-iodine-deficient
area who had regularly used iodised salt for ‡ 2 year
before becoming pregnant was compared with that in
women who began using iodised salt on becoming preg-
nant(53). The findings suggest that prolonged use of iodised
salt is associated with better maternal thyroid function,
possibly as a result of having greater intrathyroidal iodine
stores to draw on during pregnancy. In iodine-deficient
countries or regions that have weak iodised salt distribu-
tion, i.e. in countries or areas in which <90% of house-
holds are using iodised salt and the median UI is <100mg/l
in schoolchildren, supplements should be given to pregnant
women, lactating women and infants, according to the
strategy shown in Table 4(12).
Iodine nutrition in the industrialised countries: the
examples of France, the USA, Australia and the UK
and the Republic of Ireland
According to the WHO the highest prevalence of iodine
deficiency is in Europe, where the household coverage
with iodised salt is the lowest(19). It is remarkable that
Western Europe has donated substantial funds and effort
towards controlling iodine deficiency in less-industrialised
countries in Africa and Asia, but has not yet corrected
its own problem. Currently, about half the population
in Western and Central Europe is mildly iodine de-
ficient(19,20), and it is likely that unrecognised pockets of
more severe deficiency may exist in remote or dis-
advantaged populations. There are several reasons for this
position. Most European nations have weak or non-existent
governmental programmes to address iodine deficiency.
Awareness of the importance of iodine deficiency is
underestimated as many countries have not conducted
systematic assessment or monitoring of their populations.
Thus, iodine prophylaxis is weaker in most European
countries than elsewhere in the world, and laws relating
to iodised salt vary widely in Europe, as do the types and
amounts of iodine compound used for fortification(20).
France
Iodised household salt was introduced in France on a
voluntary basis in 1952 (at 10–15 mg sodium iodide/kg
salt)(54). In the mid-1990s iodine status was investigated in a
nationally-representative sample of French adults (4860
men aged 45–60 years and 7154 women aged 35–60
years)(54). The median UI in males and females was reported
Table 4. Recommendations for iodine supplementation in pregnancy and infancy in areas in which <90% of households are using iodised salt
and the median urinary iodine is <100mg/l in schoolchildren(12)
Women of child-bearing age A single annual oral dose of 400 mg iodine as iodised oil
Or
A daily oral dose of iodine as potassium iodide should be given so that the
total iodine intake meets the RNI of 150 mg iodine/d
Women who are pregnant
or lactating
A single annual oral dose of 400 mg iodine as iodized oil
Or
A daily oral dose of iodine as potassium iodide should be given so that the
total iodine intake meets the new RNI of 250mg iodine/d
Iodine supplements should not be given to a woman who has already been given
iodised oil during her current pregnancy or up to 3 months before her current
pregnancy started
Children aged 0–6 months A single oral dose of 100 mg iodine as iodised oil
Or
A daily oral dose of iodine as potassium iodide should be given so that the total
iodine intake meets the RNI of 90mg iodine/d
Should be given iodine supplements only if the mother was not supplemented
during pregnancy or if the child is not being breast-fed
Children aged 7–24 months old A single annual oral dose of 200 mg iodine as iodised oil as soon as possible after reaching
7 months of age
Or
A daily oral dose of iodine as potassium iodide should be given so that the total iodine
intake meets the RNI of 90mg iodine/d
RNI, reference nutrient intake.
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to be 85 and 82mg/l respectively, indicating mild iodine
deficiency, with an overall goitre rate of 11% for males and
14% for females. The prevalence of individuals with an
adequate UI was found to be lowest among 55–60 year olds,
with the only 35% of men and 34% of women in this age-
group having a UI ‡100mg/l. The age-related decrease in
iodine intake was thought to be a result of a reduction in
energy intake with aging and/or increased awareness of the
health benefits of reducing Na intake, which may have
reduced iodine intake from salt. Median UI were found to
display wide marked regional variations; median UI were
higher among residents living in the north-west and west
than among those living in the centre and east, independent
of age and gender. The central region (Auvergne, Limousin)
and the north-eastern areas (Alsace, Lorraine, Champagne-
Ardennes, Franche-Comte´) were found to have the highest
percentages (33 and 24 for women and 22 and 23 for men
respectively) with UI values <50mg/l. It was suggested that
these regional variations in median UI were a result of
variations in the iodine contents of local foodstuffs, as they
are dependent on native soil and water iodine content as well
as incidental addition of iodine to foods by agricultural prac-
tices, including iodine-containing fertilisers, herbicides,
disinfectants and/or iodine-supplemented livestock feed(54).
In contrast to the results in adults, a study of approxi-
mately 1500 French children aged 6–14 years conducted in
the mid-1990s has reported iodine sufficiency in four areas
of France: Lorraine; Rhoˆne-Alpes; Languedoc-Roussillon;
Midi-Pyre´ne´es(55). The mean UI was found to be 130
(SD 74)mg/l (only 10% of UI values <50mg/l), with the
prevalence of goitre, determined by ultrasound, being
4.1% in boys and 3.1% in girls.
Two studies in pregnant women in southern France have
confirmed iodine deficiency in this group. Mean UI in
pregnant women in south-west France (n 347) was found
to be 69 (SD 4)mg/l at initial presentation (before 12 weeks
of gestation) and 86 (SD 6)mg/l during the ninth month of
pregnancy(56). During pregnancy a marked decrease was
found in free thyroxine and triiodothyronine concentrations,
with an increase in TSH and thyroglobulin concentrations.
A thyroid ultrasound was performed 1–5 d after delivery in
246 mothers. Thyroid hypertrophy (defined as thyroid
volume >18 ml) was found to affect 15.4% of women
whose first trimester UI was <50mg/l, but was present in
only 3.5% of women whose first trimester UI was >100
mg/l; 11% of women were found to be goitrous (thyroid
volume >22 ml). Similar findings have recently been
reported in pregnant women in the third trimester of preg-
nancy in the Nice area (n 330); median UI was found to be
64mg/l, with 86% of women having a UI <150mg/l(57).
Median free thyroxine was found to be 12.3 pmol/l, with
41.2% of values being <12 pmol/l. Median TSH was
reported to be 1.93 mU/l, with 26.3% having a TSH
>2.5 mU/l. Thus, iodine deficiency is common in pregnant
women in southern France and may be associated with
hypothyroxinaemia and hyperthyrotopinaemia.
The USA
Recent data from the USA indicate the general population
is iodine sufficient, and iodine nutrition has improved since
the 1960s–1970s when much of the population was con-
suming excess dietary iodine. Based on the success of the
classic iodine supplementation studies in Ohio, general
prophylaxis with iodised salt was first introduced in the
state of Michigan in 1924(4). In 1948 the USA Endemic
Goitre Committee tried to introduce iodised salt to all
states by federal law, but the bill failed(4). However, the
voluntary use of iodised salt increased across the country
and adventitious iodine entered processed foods as iodine-
containing compounds were used as bread conditioners and
in the dairy industry. These trends were associated with a
decline in the prevalence of goitre(58).
By the 1970s iodine excess had become a greater con-
cern than iodine deficiency, as iodine intakes were esti-
mated to be 150–700mg/d(59). In a ten-state study of
approximately 36 000 individuals in 1975 the median UI
was found to be 250mg creatinine/g, with the goitre pre-
valence in all age-groups at 3.1%; a higher prevalence of
goitre was found among individuals with high UI values
than those with low values(60). In a subsequent study in
approximately 7800 USA children aged 9–16 years the
prevalence of goitre was reported to be 6.8%; again with
goitre being associated with higher, not lower, UI(61).
However, the higher iodine intakes were not found to be
associated with discernable thyroid dysfunction.
In the early 1970s the NHANES began to track iodine
nutrition in the USA population. NHANES I (1971–1974)
reported a median UI of 320mg/l(58). Subsequently, results
from the USA Total Diet Study suggested a decreased total
iodine content of the food supply between 1984 and
1991(62), at least partially because of a reduction in the
amount of iodine in milk and the replacement of iodine
compounds with bromine salts by the baking industry.
Although there are no national data on iodised salt use, it
is estimated that only about 60% of salt consumed in the
USA is iodised (added as potassium iodide at a con-
centration of 77 mg iodine/kg salt)(58).
NHANES III (1988–1994) reported a median UI of
145mg/l, less than half the median in NHANES I(58). An
increase in individuals with UI concentrations <50mg/l
was found (11.6% in 1988–94 v. 2.4% in 1971–4). How-
ever, the frequency of UI concentrations >500mg/l was
reported to be reduced from 27.8% to 5.3%, with the fre-
quency of UI >1000mg/l falling from 5.3% to 1.3%. Thus,
using WHO criteria(12), the data from NHANES III sug-
gested an improvement in iodine status in the USA popu-
lation, indicated by a sharp decrease in the prevalence of
iodine excess, with the median UI in the middle of the
range (100–200mg/l) signifying adequate iodine status.
However, concern was expressed that iodine intakes would
continue to fall, putting the population at risk of de-
ficiency. This situation has not arisen; in NHANES III the
median UI was shown to be stable over the 6 years of
sampling and NHANES 2000 and 2001–2002 have repor-
ted median UI of 161mg/l and 168mg/l respectively(58).
Thus, it appears the iodine intakes in the USA have stabi-
lised. However, in the 2001–2002 NHANES the UI of
pregnant women was reported to be 173 (95% CI 75,
229)mg/l, within the range recommended by WHO (150–
249mg/l), but the lower 95% CI was <150mg/l, partly
because of small sample size(63). Thus, until additional data
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become available, in order to ensure adequate iodine intake
to maintain euthyroidism for the mother and fetus during
pregnancy, the American Thyroid Association has recom-
mended that women receive 150mg iodine supplements
daily during pregnancy and lactation and that all prenatal
vitamin–mineral preparations contain 150mg iodine(63).
Australia
Australia is an industrialised country in which mild iodine
deficiency has reappeared, after having been controlled for
decades mainly by adventitious iodine in milk and milk
products. In 1992 the median UI in the Australian popu-
lation was reported to be >200mg/l, indicating iodine suf-
ficiency(64). A national survey in 2003–4 of schoolchildren
in mainland Australia aged 8–10 years (n 1709) has
reported a median UI of 104mg/l(64). In New South Wales
and Victoria children were found to be mildly iodine
deficient, with median UI of 89mg/l and 73.5mg/l respec-
tively. Based on WHO reference values by age, 5.6 and
9.3% of boys and girls respectively were found to have
increased thyroid volume, but no significant association
was demonstrated between UI and thyroid volume. These
results indicate marginal iodine intake in the Australian
population at the national level, with several of the states
being mildly iodine deficient. Tasmania was not included
in this survey, but in a study in 2001, before bread for-
tification with iodine began, the median UI in Tasmanian
schoolchildren was reported to be 84mg/l, with 20% of
values <50mg/l(65).
These data are supported by a recent cross-sectional
study of 815 pregnant women ( ‡ 28 weeks of gestation)
and 824 newborns in New South Wales(66). Spot urine
samples were measured for iodine concentration in the
women and TSH was measured in newborns at 48–72 h
after birth using a sensitive fluoroimmunoassay. The
median UI in pregnant women was reported to be 85mg/l,
indicating mild iodine deficiency, with eighteen newborns
(2.2%) having TSH values >5 mIU/l. No correlation was
found between neonatal TSH and maternal UI, but mothers
with a UI <50mg/l were shown to be 2.6 times (relative
risk 2.65 (95% CI 1.49, 4.73)) more likely to have a baby
with a TSH level >5 mIU/l.
The major sources of dietary iodine in the Australian
diet are thought to be milk and milk products, seafood
and iodised salt(67). However, few individuals purchase
iodised salt and, except in Tasmania, few if any food
manufacturers use iodised salt in the preparation and
manufacture of foods. It has been suggested that for the
last 40–50 years the largest source of iodine in the
Australian diet has been milk containing iodine residues
from sanitising iodophors used in dairying. In a 1975 sur-
vey mean iodine concentrations in cow’s milk in southern
Australia were reported to be 583–593mg/l(67). As a result
of concerns that high iodine levels in milk could lead to
iodine toxicity Food Standards Australia specified a milk
iodine limit of 500mg/l in the Food Standards Code of
1982(68), which led to the replacement of iodophors by
chlorine-containing sanitisers. Iodine content of milk sam-
ples in Sydney from 2001 to 2004 (thirteen samples per
year) were found to be highly variable but generally much
lower than in the 1970s, with median concentrations of 140
(range 60–220) mg/l in 2001 and 195 (range 66–412) mg/l
in 2004(67). It was suggested that the reduced amount of
iodine in milk is a major reason why iodine deficiency has
reappeared in regions of Australia. In 2009 a decision
was made by Food Standards Australia New Zealand to
address iodine deficiency in the population by requiring the
salt in bread to be replaced with iodised salt(69).
The UK and the Republic of Ireland
The re-emergence of iodine deficiency in Australia should
raise concern in the UK, as the pattern of a rise and fall in
iodine intakes as a result of changes in milk iodine levels
may recur in Britain. Studies in the UK in the 1800s
reported a high prevalence of goitre and occasional cre-
tinism(70). By 1900 the English goitre belt was well-
defined; it extended from the West Country through Som-
erset and northwards into Derbyshire and the Peak District,
with offshoots into North and South Wales. The high
regional goitre rates in adults and children in the 1940s led
to recommendations by the Medical Research Council in
1944 and 1948 for a programme of iodised salt throughout
the UK, but no action was taken(71). In Oxfordshire the
goitre prevalence between 1948 and 1958 was found to be
essentially unchanged in boys but increased in girls, from
27% to 40%(72). Goitre remained a health problem into the
early 1960s in Sheffield and Wales(73,74), as well as in
Glasgow, where patients presenting with non-toxic goitre
were reported to have low dietary iodine intake and low
plasma inorganic iodine concentrations(70). Although
monitoring data are scarce, it appears that since the 1960s
the prevalence of iodine deficiency and goitre has fallen in
the UK. A 1990 survey has reported the absence of thyroid
enlargement in children in a traditionally iodine-deficient
area of South Wales(75).
The improvement in iodine intakes dating from the
1960s in the UK may have been a result, at least in part, of
increasing iodine intake from milk and milk products.
Iodine supplementation of livestock improves their repro-
ductive performance and many UK dairy herds, beginning
as early as the 1920s and 1930s, have been given iodine
via iodised salt licks and/or iodine-enriched cattle feed(70).
This practice increases the iodine content of milk, par-
ticularly during the winter months, when cattle are more
dependent on iodine-rich artificial feed. In addition, the use
of iodophor disinfectants for cleaning teats and milk
tankers and giving iodinated casein to cows to promote
lactation have also contributed to higher iodine levels in
milk(70). The simultaneous increase in per capita milk
consumption has resulted in the amount of iodine provided
by milk in the UK sharply increasing; it was estimated that
average daily iodine intake from milk increased between
1930 and 1980 from approximately 5 mg to 25mg (in
summer) and >100mg (in winter)(70). The increasing con-
tribution of milk iodine is likely to be a major reason why
estimated dietary iodine intakes in the UK increased
between 1952 and 1982 from 80mg to 255mg/d(76).
However, several UK authors have suggested that the
increasing trend to replace iodine compounds used in the
dairy and baking industries with non-iodine alternatives
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may be decreasing iodine intakes, similar to the situation
that has occurred in Australia(77–82). If adventitious dietary
iodine falls, the population may be vulnerable to iodine
deficiency because iodised salt makes up <5% of all salt
consumed in the UK and the Republic of Ireland(77).
Recent measurement of the iodine content in retail salt
(thirty-six samples) in Cardiff (Wales) has shown iodine
concentrations to be undetectable in thirty-two samples,
with two samples, labelled as iodised, containing approxi-
mately 20 mg iodine/kg(77).
Limited data from Scotland(78) and north-east Eng-
land(79) suggest many pregnant women are iodine deficient.
In a study in Middlesbrough (north-east England) in 2000–
2001 pregnant women attending the antenatal clinic at 15
weeks of gestation (n 227) and non-pregnant age-matched
controls (n 227) were enrolled(79). Sixteen of the pregnant
women (7%) and twenty of the non-pregnant controls
(8.8%) were found to have UI <50mg/l, with ninety (40%)
of the pregnant women having UI between 50mg/l and
100mg/l. The 227 pregnancies resulted in 218 live births
and no newborn was reported to have a clearly elevated
blood TSH. Although it was suggested that the data indi-
cate borderline iodine deficiency in pregnancy, using the
current WHO cut-off value for inadequate iodine intake for
this group (150mg/l)(12) most of the women were clearly
iodine deficient.
In the Republic of Ireland the distribution of newborn
TSH as a measure of iodine nutrition has been examined
in the population(80). Samples drawn from the National
Neonatal Screening Programme were assessed during the
years 1995–2006. In 1995–6 the frequency of TSH values
>5.0 mIU/l was found to be >3%, suggesting iodine
deficiency in the population. However, a marked decline in
the proportion of elevated values was observed in the
subsequent years. At the same time, a small but significant
increase (P<0.001) in mean blood TSH within the 0–5.0
mIU/l interval was observed between 1999 and 2006. It
was suggested that the trend towards increasing TSH is
of concern and should be monitored carefully. UI was
measured in Irish women (n 54) during the first trimester
of pregnancy (median 8 weeks of gestation) attending the
National Maternity Hospital in Dublin(81). The samples
were taken at different times during the year with thirty-six
samples taken in the summer months. The UI were found
to show seasonal variation; the median UI in the women
being 45mg/l in summer and 68mg/l in winter. These
values are lower than those in a study of pregnant women
in Dublin in the mid-1990s from the same research
group(82), in which the median UI was reported to be
83mg/l in summer and 135mg/l in winter. Although these
studies were small, they suggest dietary iodine intake in
Irish pregnant women continues to fall well short of WHO
recommendations. This outcome is not surprising, as only
about 3–4% of total salt sales in Ireland are iodised(81).
Thus, dietary iodine intake in the Irish population depends
on consumption of sea fish and marine products, which
varies widely among regions and individuals, and milk
and dairy products, the iodine content of which varies
seasonally and may be decreasing as a result of reduced
use of iodophor disinfectants by dairies. As in the UK,
relying on unpredictable amounts of iodine in the food
supply, driven mainly by commercial rather than health
interests, is precarious. The few available data suggest that
the Republic of Ireland and the UK are mildly iodine
deficient. Representative data on current iodine status in
children and pregnant women are urgently needed to
inform health policy.
Conclusion
Mild iodine deficiency affects many industrialised coun-
tries, including Australia, New Zealand and approximately
50% of continental Europe. It is likely that pregnant
women in the Republic of Ireland and the UK are also
mildly iodine deficient, but there are few representative
data. In most industrialised countries the best strategy to
control iodine deficiency is carefully-monitored salt iodi-
sation. However, because approximately 90% of the salt
consumption in industrialised countries is from purchased
processed foods, it is critical that the food industry use
iodised salt. The current push to reduce salt consumption
to prevent chronic diseases is not at odds with salt iodisa-
tion to eliminate iodine deficiency; as salt intakes fall, the
iodine content of salt can be increased to deliver adequate
iodine, even if per capita salt intakes are reduced to
<5 g/d.
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